Friday November 27 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Hallervorden-Spatz Syndrome

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Hallervorden-Spatz Syndrome:

Pubmed Logo
Generalised dystonia: clinical diagnosis is possible.
Neurodegeneration with brain iron accumulation type 1 (previously known as...
17th July, 2009
Department of Medicine, Christian Medical College and Hospital, Vellore Hong Kong Med J. 2009 Jun;15(3):224-6.
Clinical spectrum of Hallervorden-Spatz syndrome in India.
Hallervorden-Spatz syndrome is a rare autosomal recessive disorder that...
27th March, 2009
Department of Neurology, All India Institute of Medical Sciences, Ansari J Clin Neurosci. 2009 Feb;16(2):253-8. Epub 2008 Dec 3.
DOI Direct Link
Pantothenate kinase-associated neurodegeneration in two Chinese children: identification of a novel PANK2 gene mutation.
Pantothenate kinase-associated neurodegeneration (formerly...
9th April, 2008
Department of Paediatrics and Adolescent Medicine, Princess Margaret Hong Kong Med J. 2008 Feb;14(1):70-3.
Deprivation of pantothenic acid elicits a movement disorder and azoospermia in a mouse model of pantothenate kinase-associated neurodegeneration.
We asked whether a movement disorder could be elicited by deprivation of...
19th August, 2007
Department of Medicine, University of California, San Francisco, CA, USA. J Inherit Metab Dis. 2007 Jun;30(3):310-7. Epub 2007 Apr 12.
DOI Direct Link
Neurodegeneration with brain iron accumulation: clinical, radiographic and genetic heterogeneity and corresponding therapeutic options.
BACKGROUND: Neurodegeneration with brain iron accumulation (NBIA),...
21st July, 2007
Department of Neurology, Hopital Roger Salengro, Lille, France. Acta Neurol Belg. 2007 Mar;107(1):26-31.

View more research publications.

Press Releases About Hallervorden-Spatz Syndrome:

BioPortfolio Logo
U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 25th November, 2009 Tibotec Therapeutics
- Severe, potentially life-threatening, and fatal skin reactions have been reported in patients taking INTELENCE. These include cases of Stevens-Johnson syndrome, toxic
Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 25th November, 2009 Regado Biosciences
BASKING RIDGE, N.J., Nov. 25 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that David Mazzo, PhD
Reportlinker Adds Probiotics - A Global Update of Market Trends & Opportunities 25th November, 2009 Reportlinker
NEW YORK, Nov. 25 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Probiotics - A Global Update of Market Trends & Opportunities http:/
DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 24th November, 2009 DynaVox Mayer-Johnson
PITTSBURGH, Nov. 24 /PRNewswire/ -- WHAT: Rom Houbens, a Belgian man thought to have been in coma for 23 years following an auto accident, was actually fully conscious and awake during that time and
Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 23rd November, 2009 Lexicon Pharmaceuticals, Inc.
THE WOODLANDS, Texas, Nov. 23 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today that top-line data from its Phase 2 clinical study with LX1031 in patients with

BioNews Results for Hallervorden-Spatz Syndrome:

RSS Logo
BioPortfolio Logo
Swine flu update: Children from 6 months to 5 years invited
Irish Medical Times:  Nov 21 2009 4:50AM Matching: syndrome
China responds to underreporting claim
Reuters:  Nov 21 2009 12:32AM Matching: syndrome
Study Suggests Treatment for Down's Syndrome
Modern Medicine:  Nov 21 2009 12:05AM Matching: syndrome
Study Examines Challenges Of Diagnosing Neurofibromatosis Type 1-like Syndrome
Medical News Today:  Nov 21 2009 12:04AM Matching: syndrome
Study Finds Boosting Neurotransmitter Could Reverse Down Syndrome
MedIndia:  Nov 20 2009 5:13AM Matching: syndrome
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

Hallervorden-Spatz Syndrome Patents:

USPTO Logo
US Patent No.Title
6770466 Human protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
7041803 Galectin 11
7078186 Apoptosis related polynucleotides, polypeptides, and antibodies
7087574 Brain associated inhibitor of tissue-type plasminogen activator
7091315 Protein HDPBQ71

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Hallervorden-Spatz Syndrome scientists - we have details of around 11 individuals working on Hallervorden-Spatz Syndrome .


This page has been viewed 444 times
Recent Search Terms used to find this page: hallervorden spatz syndrome | haller vorden spatz syndrome | Hallervorden Spatz syndrome | hallervorden spatz syndrome | Formerly Hallervorden-Spatz Syndrome symptoms | hallervorden-spatz disease wiki | hallervorden syndrome | hallervorden syndrome | Hallervorden-Spatz Disease wiki | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Hallervorden-Spatz Syndrome across BioPortfolio, or for Hallervorden-Spatz Syndrome Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.